About Us
Latest News
Thursday, January 26 2012. UK based BACTEST Ltd. today announced that it had closed a £900k funding round led by the Low Carbon Innovation Fund (LCIF), managed by Turquoise International, which invested £300k in BACTEST.
Bactest has created a wholly owned subsidiary to exploit its proprietory platform CYTOMAIA in the Human Health Sector. The new company GEMINI Diagnostics Ltd will focus on human clinical applications of CYTOMAIA.
Current Collaborations
Wastewater treatment relies on efficient growth of a complex mix of microorganisms within effluent as activated sludge. We are working with Anlian Water to explore the utility of Bactest’s proven, robust, rapid microbial monitoring technology (CYTOMAIA) to accurately assess the biological activity of the process in real time and translate this into meaningful data that can directly control and fine tune process parameters.
Anglian Water
Anglian Water supply water and wastewater services to more than six million domestic and business customers in the east of England.
Anglian Water provides almost 1.1 billion litres of water every single day.
The huge region stretches from the Humber north of Grimsby, to the Thames estuary and then from Buckinghamshire to Lowestoft on the east coast. Anglian Water's 80,000 km of water and wastewater pipes could take us a quarter of the way to the moon! They supply and transport water across an area of 27,500 square km.
Anglian Water are the largest water and wastewater company in England and Wales by geographic area.
Reliable estimates suggest £55 – 100 M pa is spent in electricity costs in England and Wales for secondary activated sludge treatment, mainly gassing. This translates into greater than 600 GWh of Electricity and 325,000 tons of Carbon emissions annually.
Efficient monitoring and control of biological processes can reduce this figure significantly.
Contact Us
